With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells||Stanford University School of Medicine / Alice Bertaina, MD/PhD||Reach Grants||2019||California|
|Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma||City of Hope National Medical Center / Linda Malkas, PhD||Reach Grants||2019||California|
|Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma||Beckman Research Institute of City of Hope / Margarita Gutova, MD||Reach Grants||2013||California|
|Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma||The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D.||Reach Grants||2014||California|
|A Novel Target for Neuroblastoma Treatment||Beckman Research Institute of City of Hope / Linda Malkas, Ph.D.||Reach Grants||2014||California|
|Targeting PI3Kdelta in Childhood Acute Lymphoblastic Leukemia||Children's Hospital Los Angeles / Yong-mi Kim, MD & Nora Heisterkamp, PhD||Reach Grants||2015||California|
|Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML||Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD||Reach Grants||2015||California|
|Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL||University of Colorado Denver / Doug Graham, MD, PhD||Reach Grants||2013||Colorado|
|DNA Methylation Inhibitor Therapy for Testicular Germ Cell Tumors||University of Illinois, Urbana-Champaign / Michael Spinella, Ph.D.||Reach Grants||2014||Illinois|
|Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor||Northwestern University (Illinois) / Rintaro Hashizume, MD/PhD||Reach Grants||2018||Illinois|